Skip to content
CompanySight
Company No. 14443321 · Incorporated 26 Oct 2022

Pharmacy Plus Health Limited

Registered name: PHARMACY PLUS HEALTH LIMITED

Part of Hubrx Holdings Limited group

Pharmacy Plus Health Limited made £23.4m revenue and a £7.6m loss in the year to 31 Mar 2025.

Pharmacy Plus Health Limited’s revenue fell 11% to £23.4m in the year to 31 Mar 2025, with a loss of £7.6m and 204 employees. The company is classified under “specialists medical practice activities” and is based in Leeds; we hold 3 years of its filed accounts.

Full P&L filedSection Q · Human health and social workSIC 86220Specialists medical practice activities
Status
Active
Location
Leeds, Yorkshire and The Humber
Age
3 yrs · since 2022
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “As at the year end, the immediate parent company is HubRx Ltd, a company registered in England and Wales under company number 12192691. The ultimate parent company is HubRx Holdings Limited, a company”

Latest accounts · year to 31 Mar 2025

Key figures

Revenue
£23.4m
Growth ▼10.7%
Profit
−£7.6m
Growth —
Profit margin
−32.5%
Gross 24.3%
Employees
204
Change ▲28.3%
Profit / employee
−£37.2k
Revenue/employee £115k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to14 Mar 202331 Mar 202431 Mar 2025
DisclosureNo P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)—£26.2m£23.4m
Cost of sales—£22.8m£17.7m
Gross profit—£3.4m£5.7m
Operating profit—−£11.5m−£4.2m
Profit before tax—−£14.3m−£7.6m
Profit after tax—−£14.3m−£7.6m
Profit (best available)—−£14.3m−£7.6m
Staff costs—£6.4m£5.9m
Employees (average)4159204
Ratios
Profit margin—−54.5%−32.5%
Gross margin—13%24.3%
Revenue per employee—£165k£115k
Profit per employee—−£89.8k−£37.2k
Growth (year on year)
Revenue growth——▼10.7%
Headcount growth——▲28.3%
Balance sheet — indirect signals, not revenue
Cash at bank£1£0—
Net assets£1−£14.3m−£21.9m
Fixed assets£0£18.1m£16.8m
Current assets£1£3.9m£3m
Debtors£0£1.9m£1.8m
Deferred income£0£87.7k£188k
SourceFullAccounts · bulk data Mar 2025FullAccounts · bulk data Mar 2025FullAccounts · bulk data Mar 2026
Derived from the latest filing

How the business works

Profit margin
−32.5%
Profit ÷ revenue.
Gross margin
24.3%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£115k
Revenue ÷ average employees.
Profit per employee
−£37.2k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
71.7%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
0.8%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
7.8%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£21.9m
Cash at bank
—
Now —
Headcount
▲28%
Now 204
Deferred income
▲114%
Now £188k
Fixed assets
▼7%
Now £16.8m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Hubrx Holdings Limitedultimate parent75–100%
  2. Hubrx Ltd75–100%
  3. Pharmacy Plus Health Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (4)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£7.6m), from the Companies House accounts bulk data published Mar 2026. Spotted an error? Request a correction.

Updated from Companies House on 13 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.